×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Aarti Pharmalabs Limited | 3769.06 | 512.21 | 3753.11 | 0 | 7,991 | 30.0 |
| MARKSANS PHARMA LTD. | 3217.44 | 480.56 | 3197.34 | 1.06 | 7790 | 22.2 |
| YATHARTH HOSPITAL & TRAUMA CAR | 1374.03 | 271.22 | 1301.44 | 2.81 | 7583 | 53.3 |
Aarti Pharmalabs Limited, with Security Code 543748, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 374.3 | 358.1 | 356.1 | 373.0 | 414.8 | 393.5 | 377.3 | 470.9 | 529.6 | 375.3 |
| Expenses | 297.5 | 281.4 | 282.4 | 284.8 | 307.5 | 309.8 | 292.5 | 356.0 | 386.5 | 280.2 |
| Operating Profit | 76.8 | 76.7 | 73.8 | 88.3 | 107.3 | 83.7 | 84.8 | 115.0 | 143.1 | 95.1 |
| OPM % | 20.52% | 21.43% | 20.72% | 23.66% | 25.88% | 21.26% | 22.47% | 24.42% | 27.03% | 25.35% |
| Other Income | 0.0 | 4.9 | 0.0 | 0.2 | 5.7 | 2.1 | 2.9 | 11.9 | -2.5 | 1.6 |
| Interest | 5.8 | 4.0 | 3.8 | 4.1 | 4.4 | 4.2 | 5.4 | 9.7 | 6.3 | 6.8 |
| Depreciation | 14.3 | 15.4 | 16.3 | 16.9 | 17.3 | 18.3 | 18.9 | 21.0 | 20.8 | 22.8 |
| Profit before tax | 56.7 | 62.1 | 53.7 | 67.4 | 91.3 | 63.2 | 63.4 | 96.2 | 113.5 | 67.2 |
| Tax % | -29.5% | -23.3% | -22.1% | -28.5% | -31% | -25.4% | 24.6% | -23.6% | -21.7% | 23.7% |
| Net Profit | 40.0 | 47.6 | 41.2 | 48.2 | 63.0 | 47.1 | 47.8 | 73.5 | 88.8 | 51.2 |
| EPS in Rs | 4.41 | 5.26 | 4.61 | 5.32 | 6.95 | 5.2 | 5.27 | 8.11 | 0 | 5.65 |
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 485.1 | 458.4 | 439.8 | 448.7 | 505.8 | 555.5 | 458.0 | 537.8 | 563.8 |
| Expenses | 405.1 | 373.5 | 351.8 | 353.0 | 388.2 | 459.0 | 364.4 | 409.2 | 418.1 |
| Operating Profit | 80.0 | 84.9 | 88.0 | 95.7 | 117.5 | 96.5 | 93.7 | 128.6 | 145.7 |
| OPM % | 16.49% | 18.52% | 20.01% | 21.32% | 23.24% | 17.36% | 20.45% | 23.92% | 25.84% |
| Other Income | 0.7 | 0.5 | 1.0 | 1.4 | 2.0 | 2.2 | 4.5 | 5.0 | -1.6 |
| Interest | 5.9 | 4.2 | 3.9 | 4.5 | 4.7 | 4.8 | 5.5 | 10.0 | 6.6 |
| Depreciation | 16.0 | 17.2 | 18.1 | 18.8 | 19.1 | 20.2 | 20.9 | 23.0 | 22.8 |
| Profit before tax | 58.8 | 64.0 | 67.0 | 73.8 | 95.8 | 73.7 | 71.8 | 100.6 | 114.7 |
| Tax % | -27.1% | -26.4% | -22.6% | -28.5% | 31.9% | 24.7% | -23.9% | 26.5% | -22.9% |
| Net Profit | 42.9 | 47.1 | 51.8 | 52.8 | 65.3 | 55.5 | 54.6 | 74.0 | 88.3 |
| EPS in Rs | 4.73 | 5.2 | 5.72 | 5.82 | 7.2 | 6.12 | 6.02 | 8.16 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 23% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 564% |
| 3 Years: | 34% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 44% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 21% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 31% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 44% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|